UBS Raises Apellis Pharmaceuticals Shares Target Following Promising Forecast
Monday, 4 March 2024, 12:02
UBS Raises Apellis Pharmaceuticals Shares Target
UBS has raised the target for Apellis Pharmaceuticals shares, based on a promising outlook. The move indicates strong confidence in the company's future prospects.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.